Last reviewed · How we verify
Yiqi Huoxue Huatan granule
Yiqi Huoxue Huatan granule is a Small molecule drug developed by Peking University People's Hospital. It is currently in Phase 3 development for Chronic obstructive pulmonary disease (COPD) or related respiratory conditions, Cardiovascular conditions associated with qi deficiency and blood stasis (TCM indication). Also known as: Tiotropium Bromide Powder for Inhalation, Salmeterol / Fluticasone Powder for Inhalation or Budesonide / Formoterol Powder for Inhalation.
A traditional Chinese medicine granule formulation that aims to improve qi circulation, promote blood flow, and resolve phlegm/sputum accumulation.
A traditional Chinese medicine granule formulation that aims to improve qi circulation, promote blood flow, and resolve phlegm/sputum accumulation. Used for Chronic obstructive pulmonary disease (COPD) or related respiratory conditions, Cardiovascular conditions associated with qi deficiency and blood stasis (TCM indication).
At a glance
| Generic name | Yiqi Huoxue Huatan granule |
|---|---|
| Also known as | Tiotropium Bromide Powder for Inhalation, Salmeterol / Fluticasone Powder for Inhalation or Budesonide / Formoterol Powder for Inhalation |
| Sponsor | Peking University People's Hospital |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular / Respiratory (TCM-based) |
| Phase | Phase 3 |
Mechanism of action
Yiqi Huoxue Huatan granule is a herbal compound used in Traditional Chinese Medicine (TCM) practice. The name translates to 'Qi-Supplementing, Blood-Invigorating, Phlegm-Resolving' granule, reflecting its intended mechanism of enhancing energy (qi) circulation, improving microvascular blood flow, and reducing pathological sputum/phlegm. The formulation typically combines multiple herbal ingredients believed to work synergistically on these TCM principles.
Approved indications
- Chronic obstructive pulmonary disease (COPD) or related respiratory conditions
- Cardiovascular conditions associated with qi deficiency and blood stasis (TCM indication)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Yiqi Huoxue Huatan granule CI brief — competitive landscape report
- Yiqi Huoxue Huatan granule updates RSS · CI watch RSS
- Peking University People's Hospital portfolio CI
Frequently asked questions about Yiqi Huoxue Huatan granule
What is Yiqi Huoxue Huatan granule?
How does Yiqi Huoxue Huatan granule work?
What is Yiqi Huoxue Huatan granule used for?
Who makes Yiqi Huoxue Huatan granule?
Is Yiqi Huoxue Huatan granule also known as anything else?
What development phase is Yiqi Huoxue Huatan granule in?
Related
- Manufacturer: Peking University People's Hospital — full pipeline
- Therapeutic area: All drugs in Cardiovascular / Respiratory (TCM-based)
- Indication: Drugs for Chronic obstructive pulmonary disease (COPD) or related respiratory conditions
- Indication: Drugs for Cardiovascular conditions associated with qi deficiency and blood stasis (TCM indication)
- Also known as: Tiotropium Bromide Powder for Inhalation, Salmeterol / Fluticasone Powder for Inhalation or Budesonide / Formoterol Powder for Inhalation
- Compare: Yiqi Huoxue Huatan granule vs similar drugs
- Pricing: Yiqi Huoxue Huatan granule cost, discount & access